167 related articles for article (PubMed ID: 34952633)
1. Preliminary demonstration of benchtop NMR metabolic profiling of feline urine: chronic kidney disease as a case study.
Finch N; Percival B; Hunter E; Blagg RJ; Blackwell E; Sagar J; Ahmad Z; Chang MW; Hunt JA; Mather ML; Tasker S; De Risio L; Wilson PB
BMC Res Notes; 2021 Dec; 14(1):469. PubMed ID: 34952633
[TBL] [Abstract][Full Text] [Related]
2. A pilot metabolic profiling study in serum of patients with chronic kidney disease based on (1) H-NMR-spectroscopy.
Qi S; Ouyang X; Wang L; Peng W; Wen J; Dai Y
Clin Transl Sci; 2012 Oct; 5(5):379-85. PubMed ID: 23067349
[TBL] [Abstract][Full Text] [Related]
3. Targeted and untargeted serum NMR metabolomics to reveal initial kidney disease in diabetes mellitus.
Lucio-Gutiérrez JR; Cordero-Pérez P; Ávila-Velázquez JL; Torres-González L; Farías-Navarro IC; Govea-Torres G; Sánchez-Martínez C; García-Hernández PA; Coello-Bonilla J; Pérez-Trujillo M; Parella T; Waksman-Minsky NH; Saucedo AL
J Pharm Biomed Anal; 2024 Sep; 247():116240. PubMed ID: 38820837
[TBL] [Abstract][Full Text] [Related]
4. Rule-Mining for the Early Prediction of Chronic Kidney Disease Based on Metabolomics and Multi-Source Data.
Luck M; Bertho G; Bateson M; Karras A; Yartseva A; Thervet E; Damon C; Pallet N
PLoS One; 2016; 11(11):e0166905. PubMed ID: 27861591
[TBL] [Abstract][Full Text] [Related]
5. In-depth characterisation of the urine metabolome in cats with and without urinary tract diseases.
Kim Y; Xu W; Barrs V; Beatty J; Kenéz Á
Metabolomics; 2022 Mar; 18(4):19. PubMed ID: 35305176
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities in metabolic pathways in celiac disease investigated by the metabolic profiling of small intestinal mucosa, blood plasma and urine by NMR spectroscopy.
Upadhyay D; Singh A; Das P; Mehtab J; Dattagupta S; Ahuja V; Makharia GK; Jagannathan NR; Sharma U
NMR Biomed; 2020 Aug; 33(8):e4305. PubMed ID: 32394522
[TBL] [Abstract][Full Text] [Related]
7. Urinary proteome and metabolome in dogs (Canis lupus familiaris): The effect of chronic kidney disease.
Ferlizza E; Isani G; Dondi F; Andreani G; Vasylyeva K; Bellei E; Almeida AM; Matzapetakis M
J Proteomics; 2020 Jun; 222():103795. PubMed ID: 32335294
[TBL] [Abstract][Full Text] [Related]
8. Untargeted plasma
Fonseca RID; Menezes LRA; Santana-Filho AP; Schiefer EM; Pecoits-Filho R; Stinghen AEM; Sassaki GL
J Pharm Biomed Anal; 2023 May; 229():115339. PubMed ID: 36963247
[TBL] [Abstract][Full Text] [Related]
9. Application of nuclear magnetic resonance spectroscopy for the detection of metabolic disorders in patients with moderate kidney insufficiency.
Mika A; Wojtowicz W; Ząbek A; Młynarz P; Chmielewski M; Sledzinski T; Stepnowski P
J Pharm Biomed Anal; 2018 Feb; 149():1-8. PubMed ID: 29100025
[TBL] [Abstract][Full Text] [Related]
10.
Duan X; Zhang T; Ou L; Kong Z; Wu W; Zeng G
Urolithiasis; 2020 Feb; 48(1):27-35. PubMed ID: 30949730
[TBL] [Abstract][Full Text] [Related]
11. Nuclear magnetic resonance-based targeted profiling of urinary acetate and citrate following cyclophosphamide therapy in patients with lupus nephritis.
Ganguly S; Kumar U; Gupta N; Guleria A; Majumdar S; Phatak S; Chaurasia S; Kumar S; Aggarwal A; Kumar D; Misra R
Lupus; 2020 Jun; 29(7):782-786. PubMed ID: 32299281
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency Cohort Study.
Rhee EP; Clish CB; Wenger J; Roy J; Elmariah S; Pierce KA; Bullock K; Anderson AH; Gerszten RE; Feldman HI
Am J Nephrol; 2016; 43(5):366-74. PubMed ID: 27172772
[TBL] [Abstract][Full Text] [Related]
13. The effects of a hydrolyzed protein diet on the plasma, fecal and urine metabolome in cats with chronic enteropathy.
Kathrani A; Yen S; Hall EJ; Swann JR
Sci Rep; 2023 Nov; 13(1):19979. PubMed ID: 37968311
[TBL] [Abstract][Full Text] [Related]
14. Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease.
Chen DQ; Cao G; Chen H; Liu D; Su W; Yu XY; Vaziri ND; Liu XH; Bai X; Zhang L; Zhao YY
Redox Biol; 2017 Aug; 12():505-521. PubMed ID: 28343144
[TBL] [Abstract][Full Text] [Related]
15. Using nuclear magnetic resonance urine metabolomics to develop a prediction model of early stages of renal disease in subjects with type 2 diabetes.
Lucio-Gutiérrez JR; Cordero-Pérez P; Farías-Navarro IC; Tijerina-Marquez R; Sánchez-Martínez C; Ávila-Velázquez JL; García-Hernández PA; Náñez-Terreros H; Coello-Bonilla J; Pérez-Trujillo M; Parella T; Torres-González L; Waksman-Minsky NH; Saucedo AL
J Pharm Biomed Anal; 2022 Sep; 219():114885. PubMed ID: 35779355
[TBL] [Abstract][Full Text] [Related]
16. Urinary F
Whitehouse W; Quimby J; Wan S; Monaghan K; Robbins R; Trepanier LA
J Vet Intern Med; 2017 Mar; 31(2):449-456. PubMed ID: 28160524
[TBL] [Abstract][Full Text] [Related]
17. Dominant components of the Thoroughbred metabolome characterised by (1) H-nuclear magnetic resonance spectroscopy: A metabolite atlas of common biofluids.
Escalona EE; Leng J; Dona AC; Merrifield CA; Holmes E; Proudman CJ; Swann JR
Equine Vet J; 2015 Nov; 47(6):721-30. PubMed ID: 25130591
[TBL] [Abstract][Full Text] [Related]
18. Analytical validation of a human particle-enhanced nephelometric assay for cystatin C measurement in feline serum and urine.
Ghys LF; Meyer E; Paepe D; Delanghe J; Daminet S
Vet Clin Pathol; 2014 Jun; 43(2):226-34. PubMed ID: 24773065
[TBL] [Abstract][Full Text] [Related]
19. Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis.
Romick-Rosendale LE; Brunner HI; Bennett MR; Mina R; Nelson S; Petri M; Kiani A; Devarajan P; Kennedy MA
Arthritis Res Ther; 2011; 13(6):R199. PubMed ID: 22152586
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
